<DOC>
	<DOCNO>NCT00266864</DOCNO>
	<brief_summary>It long recognize co-morbidity associate multiple metabolic syndrome , adverse body composition , insulin resistance autonomic nervous system impairment , may lead significant increase cardiovascular morbidity mortality . It unclear whether co-morbidity evident population due directly immobility result unfavorable change underlie hormonal milieu . The purpose study determine effect testosterone replacement therapy hypogonadal male : body composition , i.e . lean tissue fat mass , glucose tolerance , rest energy expenditure , autonomic-cardiovascular integrity , muscular strength , psychological assessment</brief_summary>
	<brief_title>Testosterone Replacement Therapy Chronic Spinal Cord Injury</brief_title>
	<detailed_description>This study 24 month duration . Men consent pre-screening serum testosterone draw find total testosterone level average ≤ 11.3 nmol/l start testosterone replacement therapy 6-month baseline period . Once treatment begin subject place testosterone replacement patch ( 5 10 mg/day ) various site body daily . Subjects visit lab 2,6 , 12 , 18 month therapy test ; however stop take patch 12 month visit . If need , steroid cream provide subject skin irritation occur . If patch cause persistent skin irritation , despite use steroid cream , testosterone gel may use . Detailed instruction precaution use gel outline consent form review subject . Those men consent pre-screening serum testosterone find normal level total testosterone ( testosterone total ≥ 11.4 nmol/l ) eligible participate control subject full 24-month period study . These subject visit lab baseline ( BL ) , 12 24 month test treatment group .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Males 1849 year age Chronic spinal cord injury Normal prostate specific antigen level digital rectal exam No know cardiovascular disease Subjects total testosterone &gt; 4 ng/ml Subjects total testosterone &gt; 4 ng/ml Females Known coronary heart and/or artery disease , diabetes mellitus Previous current cancer Current previous anabolic steroid use Acute intercurrent illness Abnormal liver function test ( &gt; 1.5 time normal value ) baseline Prostate specific antigen normal Abnormal digital rectal exam baseline suggestive malignancy Current alcohol drug abuse Significant psychological disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Spinal Cord Injury</keyword>
	<keyword>Testosterone Replacement Therapy</keyword>
	<keyword>Dual Energy X ray Absorptiometry</keyword>
	<keyword>Lean Tissue Mass</keyword>
</DOC>